These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 17047096)

  • 1. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
    Shimamoto K
    Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
    Bozzo L; Chatton JY
    Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
    Apricò K; Beart PM; Crawford D; O'Shea RD
    J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
    Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
    Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of [3H]L-glutamate uptake from L-glutamate-induced [3H]D-aspartate release by 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs.
    Funicello M; Conti P; De Amici M; De Micheli C; Mennini T; Gobbi M
    Mol Pharmacol; 2004 Sep; 66(3):522-9. PubMed ID: 15322243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [(3)H]-(2S,4R)-4-methylglutamate and [(3)H]D-aspartate as ligands for binding and autoradiographic analyses of glutamate transporters.
    Apricò K; Beart PM; Crawford D; O'shea RD
    Neurochem Int; 2007 Dec; 51(8):507-16. PubMed ID: 17590480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport.
    Re DB; Nafia I; Melon C; Shimamoto K; Kerkerian-Le Goff L; Had-Aissouni L
    Glia; 2006 Jul; 54(1):47-57. PubMed ID: 16673373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
    Bridges RJ; Esslinger CS
    Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of carbamate-type caged derivatives of a novel glutamate transporter blocker.
    Takaoka K; Tatsu Y; Yumoto N; Nakajima T; Shimamoto K
    Bioorg Med Chem; 2004 Jul; 12(13):3687-94. PubMed ID: 15186854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
    Jensen AA; Bräuner-Osborne H
    Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate transport by retinal Muller cells in glutamate/aspartate transporter-knockout mice.
    Sarthy VP; Pignataro L; Pannicke T; Weick M; Reichenbach A; Harada T; Tanaka K; Marc R
    Glia; 2005 Jan; 49(2):184-96. PubMed ID: 15390100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
    Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
    Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
    Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
    Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage.
    Hinoi E; Wang L; Takemori A; Yoneda Y
    Biochem Pharmacol; 2005 Jul; 70(1):70-81. PubMed ID: 15894296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
    Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
    J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
    Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
    Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of L-[14C]cystine and L-[14C]cysteine by subtypes of high affinity glutamate transporters over-expressed in HEK cells.
    Hayes D; Wiessner M; Rauen T; McBean GJ
    Neurochem Int; 2005 Jun; 46(8):585-94. PubMed ID: 15863236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
    Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
    J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.